secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001493152-25-008040
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics reprices outstanding stock options to $0.2655 per share
-------------------------------------------------------------------------------

- Stockholders approved repricing of options under 2006 and 2016 Equity Incentive Plans.
- Original exercise prices ranged from $1.74 to $19.92; repriced to $0.2655 per share.
- New exercise price equals closing common stock price on February 21, 2025.
- Action intended to retain and incentivize option holders, including officers and employees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315225008040/0001493152-25-008040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315225008040/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-008040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer